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With 100 billion neurons and 100 trillion synapses, the human brain is not just the
most complex organ in the human body, but has also been described as “the most
complex thing in the universe.” The limited availability of human living brain tissue for the
study of neurogenesis, neural processes and neurological disorders has resulted in more
than a century-long strive from researchers worldwide to model the central nervous
system (CNS) and dissect both its striking physiology and enigmatic pathophysiology.
The invaluable knowledge gained with the use of animal models and post mortem
human tissue remains limited to cross-species similarities and structural features,
respectively. The advent of human induced pluripotent stem cell (hiPSC) and 3-D
organoid technologies has revolutionised the approach to the study of human brain and
CNS in vitro, presenting great potential for disease modelling and translational adoption
in drug screening and regenerative medicine, also contributing beneficially to clinical
research. We have surveyed more than 100 years of research in CNS modelling and
provide in this review an historical excursus of its evolution, from early neural tissue
explants and organotypic cultures, to 2-D patient-derived cell monolayers, to the latest
development of 3-D cerebral organoids. We have generated a comprehensive summary
of CNS modelling techniques and approaches, protocol refinements throughout the
course of decades and developments in the study of specific neuropathologies. Current
limitations and caveats such as clonal variation, developmental stage, validation of
pluripotency and chromosomal stability, functional assessment, reproducibility, accuracy
and scalability of these models are also discussed.
Keywords: CNS, hiPSC, human neurons, human glia, neurogenesis, neurological disorders, cerebral organoids,
organotypic
INTRODUCTION
The study of neurogenesis (summarised in Figure 1), neural processes and neurological disorders
is a very challenging science, as the brain is a uniquely complex organ and is largely inaccessible for
experimental investigations in living humans, which is mostly limited to discarded post-surgical
tissue samples or neuroimaging, transcranial magnetic stimulation and electroencephalography
studies (Komssi and Kähkönen, 2006; Stan et al., 2006; Brammer, 2009; Eyal et al., 2016).
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FIGURE 1 | Process of neurogenesis. The CNS originates from the ectoderm layer of the trilaminar germ disc. The process of neurogenesis begins with the
formation of the neuroepithelium from the neuroectoderm, giving rise to the neural tube in a process called primary neurulation (Johns, 2014). The trilaminar germ
layer disc is composed of the three germ layer tissues, the endoderm, mesoderm and ectoderm. The mesoderm gives rise to the notochord, a tubular mesodermal
structure which on releasing trophic factors, triggers neural induction, whereby uncommitted or naïve ectoderm becomes committed to the neural lineage, and
subsequently stimulates the formation of the neural tube in the overlying ectoderm (Dickinson et al., 1995). As the ectoderm acquires a neuroectoderm identity, it
forms a fold, initially giving rise to the neural plate and subsequently forms the neural fold. The grooves at either side of the fold are called the neural crest. The crest
then detaches from the margins of the neural fold giving rise to the peripheral nervous system. The neural plate continues to fold on itself giving rise to the hollow
neural tube; the lumen of the neural tube is called neural canal. As the neural tube closes, it forms a fluid filled cavity that generates the ventricular zone, an area
occupied by progenitor cells such as neuroblasts and glioblasts (Johns, 2014; Brodal, 2016; Kelava and Lancaster, 2016a). In the transverse section of the neural
tube the VZ, intermediate zone and subventricular area can be seen. In the VZ mitosis takes place generating radial glia during neurogenesis.
While animal models have appreciably advanced
the understanding of human brain development and
neurodegenerative diseases, the inherent developmental,
anatomical and physiological differences between the central
nervous system (CNS) of animals and the human can add
complexity to the interpretation of findings (Elston et al., 2001;
DeFelipe et al., 2002; Roth and Dicke, 2005; Herculano-Houzel,
2009; Mohan et al., 2015). A detailed discussion of these models
would go beyond the scope of this review and it has been reported
elsewhere (Chesselet and Carmichael, 2012; Dawson et al., 2018).
As such, the current understanding of human brain development
has been limited to common features shared with other animal
species (Kelava and Lancaster, 2016b). Although centuries of
human post mortem tissue examinations have contributed to
the fundaments of modern neuroscience, allowing the study
of specific features of the human brain, these tissues cannot
be implemented in functional studies (Filis et al., 2010; Kelava
and Lancaster, 2016a). Consequently, researchers have strived
to develop and optimise in vitro neural culture systems for
advancing the understanding of the functioning of the CNS and
the underlying pathogenesis of neurological diseases. Animal
models, ex vivo and post mortem tissues have been utilised in
other areas of brain research.
The seminal work of the pioneering “fathers” of neuroscience
and Nobel laureates, Santiago Ramón y Cajal and Camillo
Golgi provided the foundations for investigating the intricacies
of the human nervous system’s macro and micro anatomy
(Ramón y Cajal, 1904; Golgi, 1906). In his published volumes,
Santiago Ramón y Cajal artistically summarised his work
describing the structure and organisation of the vertebrate
nervous systems and discussed his theories including, amongst
others, the “neuron doctrine,” the law of dynamic, functional
or axipetal polarisation of electrical activity in neurons and
his ideas on neurogenesis, neural plasticity and neuronal
regeneration/degeneration (Ramón y Cajal, 1894, 1904, 1909,
1913). Since then, neuroscientists have strived on the wealth
of knowledge inherited from Cajal and Golgi, who immensely
contributed to the evolution of modern neuroscience over
these centuries.
In this review, we present an evolutionary overview of
CNS modelling through an historical excursus (Figure 2),
starting from the origins of neural cell cultures from tissue
explants and organotypic cultures, to cell monolayers, aggregates
and ultimately leading to the generation of complex three-
dimensional (3-D) cultures such as cerebral organoids from
patient-specific isolated cells, emphasising the growing
excitement for the latter in the quest for the most representative
human CNS model.
TISSUE EXPLANTS AND ORGANOTYPIC
CULTURES
The first in vitro nervous system culture was established by
Ross Harrison in 1907, where frog embryo grafts consisting of
pieces of medullary tubes were cultured as hanging drops in
lymph. Although Harrison was able to observe neurite extensions
and maintained the culture for up to 4 weeks, it was not
possible to generate permanent specimens with intact nerve
fibres (Harrison, 1907, 1910). Decades later, the first culture of
intact CNS from chick embryos was established, permitting the
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 April 2019 | Volume 13 | Article 129
fncel-13-00129 April 8, 2019 Time: 7:55 # 3
Pacitti et al. Evolution of in vitro CNS Modelling
FIGURE 2 | Evolution timeline of CNS modelling. The timeline illustrates the evolution from organ explants to the use of 2-D neural cell lines, and subsequently a shift
toward pluripotent stem cell derived neural cultures leading to the development of CNS specific organoids. For each category of modelling a time excursus is
presented chronologically over 100 years.
recapitulation of the developing brain architecture in vitro, by
displaying the formation of early retinal tissue (Hoadley, 1924;
Waddington and Cohen, 1936).
The original long term culture (up to 143 days) of human
foetal brains was established in 1946 by Mary Jane Hogue by
using the roller tube approach (Hogue, 1946, 1947). Costero and
Pomerat (1951) successfully cultured neurons obtained from the
cerebral and cerebellar cortex explants of adult human brains, for
up to 5 weeks, using Maximow’s flying-drop.
The first CNS organotypic culture was pioneered by Bousquet
and Meunier (1962) using rat hypophysis. In 1966, Crain
cultured explants from embryonic rat spinal cord and ganglia
on collagen coated glass demonstrating that grafted neural
tissue possessed organotypic differentiation and bioelectric
properties for electrophysiological studies (Crain, 1966). Since
then, brain slices of several cerebral areas have been established
as organotypic cultures, including the hippocampus, substantia
nigra, locus coeruleus, striatum and basal forebrain (LaVail and
Wolf, 1973; Whetsell et al., 1981; Knopfel et al., 1989; Ostergaard
et al., 1995; Robertson et al., 1997).
Although tissue explants and organotypic slice cultures more
accurately recapitulate the cerebral cytoarchitecture, they are
difficult to acquire and cell specific functional studies are
subject to severe limitations (Kelava and Lancaster, 2016b).
For instance, the handling of organotypic preparations remains
quite challenging with respect to preserving the sterility, viability
and the cytoarchitecture of the tissues (Walsh et al., 2005).
Additionally, cell maturation in culture may differ within the
explanted tissues, with some cell types displaying a mature
phenotype while others remain immature, being dependent
on the age of the subject at the time of tissue collection
(Gähwiler, 1981).
2-D NEURAL CELL CULTURES
The improvement in the ability to maintain cell cultures for
extended periods has enabled a range of isolated primary
nerve cell cultures to be established, including hippocampal
neurons derived from rat foetuses (Dotti et al., 1988), cortical,
hippocampal, cerebellar and midbrain neurons from rat embryos
(Brewer, 1995; Lingor et al., 1999), forebrain neurons of adult
canaries (Goldman, 1990) and primary microglia from cerebral
tissues of neonatal rats (Giulian and Baker, 1986). The generation
of glial cell cultures, viable for several weeks, was also achieved
as described in the seminal study by McCarthy and De Vellis;
dissociated cerebral cortices of 1–2 days old rat pups brains were
used to isolate primary astrocytes and oligodendrocytes that were
devoid of any viable neuronal cell (McCarthy and de Vellis, 1980).
Culturing of primary neural cells, however, is hampered
by a limited culture lifespan and the finite number of
achievable passages with non-proliferating quiescent mature
neurons (Gordon et al., 2013). To overcome this, the first
neural stem cells (NSCs) were isolated from rat forebrains in
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1989, establishing a self-renewing line of multipotent progenitors
with the plasticity to generate progenies of the main neuronal
phenotypes (Temple, 1989).
In 1992, Reynold and Weiss demonstrated the presence of
NSCs in the adult CNS of murine brains through the isolation
of nestin expressing cells from the striata and inducing their
differentiation into neurons and astrocytes in vitro, thereby
establishing appropriate culture conditions to demonstrate the
functional attributes of these stem cells (Reynolds and Weiss,
1992). The availability of NSCs facilitated the culture of
neuronal or glial cells, without the need for complex and
laborious isolations of the latter cells from whole explants
(Gordon et al., 2013).
In parallel, the development of immortalised cell lines
eliminated the need for multiple acquisitions of tissue for neural
cell culturing. The first immortalised neuronal line was derived
from lymph nodes, infiltrated bone marrow and liver tissue of
children with neuroblastoma cancer; these cells were cultured
in vitro for up to 1 year and were capable of differentiating into
tissues resembling mature ganglion cells (Goldstein et al., 1964).
However due to the clinical heterogeneity of neuroblastoma,
cultured cells were characterised by morphological variability,
and thus efforts were made to develop more defined cell lines and
improve the longevity of cultures (Biedler et al., 1973). This led
to the generation of the SK-N-SH neuroblastoma cell line from
metastatic bone tumour (Biedler et al., 1973), which was further
subcloned to establish the widely used SH-SY5Y neuroblastoma
line (Biedler et al., 1978).
To induce cells to display a more neuronal phenotype,
the culture environment can be manipulated by the addition
of growth factors and signalling molecules such as retinoids
and dibutyryl cAMP (Kuff and Fewell, 1980; Kovalevich and
Langford, 2013); this is exemplified by the experiment conducted
by Pahlman et al. (1984), where neuroblastoma cells were exposed
to retinoic acid to display a neuroblast-like phenotype expressing
immature neuronal markers (Pahlman et al., 1984).
Other secondary immortalised cell lines developed for
modelling neuronal cells include the mouse neuroblastoma
Neuro-2a (LePage et al., 2005), PC12, a rat derived
adrenal pheochromocytoma line (Greene and Tischler,
1976), the immortalised LUHMES cell line from human
embryonic mesencephalic tissue and NT2 cells, a human
neuronally committed teratoma derived line capable of
differentiating into a mixed population of neuronal and glial
cells under retinoic acid exposure (Pleasure and Lee, 1993;
Coyle et al., 2011).
In neurobiology, the majority of primary neuronal tissue
cultures is derived from animal sources, and as such, the
techniques used to develop them suffered the same limitations
of animal models, such as costs, ethical considerations, the
obvious inter-species differences and the incorrect assumption
that orthologous genes share similar functions in closely related
living systems (Hartung, 2008; Gharib and Robinson-Rechavi,
2011; Ko and Frampton, 2016; Shipley et al., 2016). Moreover, the
main concern with using immortalised cell lines for the study of
neurobiology and for modelling neurological conditions, is that
these cells contain genetic and metabolic abnormalities which
may not represent a normal cell or those of human patients
(Gordon et al., 2013; Carter and Shieh, 2015).
In 1999, Vescovi et al. established the first human
multipotent NSCs derived from a 10.5-week embryonic
diencephalon (Vescovi et al., 1999). The establishment of
human NSCs opened exciting opportunities in neurobiology,
since normal cells of human derivation, with self-
renewing and long-term culturing capabilities, could be
used for the generation of a multitude of functional
neuronal and glial progenies for disease modelling and
potential clinical applications (Carpenter et al., 1999;
Jakel et al., 2004).
Although efforts for the successful long-term in vitro culturing
of NSCs have been made (Sun et al., 2008), these cells were found
to be incapable of accurately representing stem cells in vivo, due
to their inability to recapitulate the entire range of neural lineages
and hence brain development (Conti and Cattaneo, 2010; Kelava
and Lancaster, 2016b).
More recently, multipotent neural cells were obtained by
direct conversion of fibroblasts by the ectopic expression of
ASCL1, BRN2A and MYT1L (Vierbuchen et al., 2010) or by the
sole expression of SOX2 (Ring et al., 2012). However, it is not
clear to what extent the reprogrammed neural progenitors are
capable of retaining epigenetic memory and the fidelity of the
resemblance with neural progenitors is yet to be determined
(Velasco et al., 2014).
HUMAN PLURIPOTENT STEM
CELL-DERIVED NEURAL CULTURES
The advent of human embryonic stem cells (ESCs) in 1998
(Thomson et al., 1998) and then human induced pluripotent
stem cells (iPSC) in 2007 (Takahashi et al., 2007), have provided
exciting prospects in the field of neuroscience. The tremendous
plasticity of these cells as an unlimited source of specific cell
types, and their replicative capacity in vitro, rendered them the
ideal candidate for neurodevelopmental studies. In particular,
the possibility to generate neuronal cells directly from iPS cells
derived from patients affected by a specific disorder provides an
unprecedented opportunity to study the very phenotype of these
diseases in vitro. Figure 3, summarises the different methods of
derivation of iPSCs and the various characterisation criteria for
qualifying as pluripotent cells.
The differentiation of ESCs in vitro reproduces with great
fidelity the in vivo neuroectoderm formation (Wu et al., 2010),
and indeed, neuronal cells were amongst the first lineages
to be differentiated using PSC technology (Reubinoff et al.,
2001; Zhang et al., 2001). This was first achieved using ESCs,
by inducing their neuronal differentiation in spheroid-like
aggregates of cells [called embryoid bodies (EBs)], cultured
in serum-free conditions to selectively promote the growth of
neural cells, which self-organised to form rosettes (Zhang et al.,
2001). These rosettes generated structures reminiscent of neural
tubes (Curchoe et al., 2012), organised as progenitor zones
resembling the ventricular and subventricular zones (SVZs) with
the presence of radial glia (Shi et al., 2012b; Edri et al., 2015).
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FIGURE 3 | Induced pluripotent stem cell (iPSC) derivation and characterisation. The ectopic overexpression of the transcription factors OCT3/4, KLF4, SOX2,
L-MYC, LIN28, known to be expressed in ESCs, reverts mature somatic cells such as dermal fibroblasts and peripheral blood mononuclear cells (PBMC) to display a
pluripotent embryonic-like phenotype (Takahashi et al., 2007; Okita et al., 2013). Transfection of cells with vectors expressing these transcription factors enables the
epigenetic reprogramming of cells, through a series of stochastic events, to express endogenous OCT4 and NANOG, the characteristic transcription factors
determining the pluripotency, self-renewal and proliferative capacity of cells (Lohle et al., 2012). In synergy, the ectopic overexpression of these genes triggers a
sequence of epigenetic modifications leading to DNA demethylation and chromatin changes that eventually result in the acquisition of a pluripotent state in
transfected cells (Jaenisch and Young, 2008). A multitude of vectors have been used to deliver the reprogramming factors and these approaches are broadly divided
into non-viral and viral, and integration and non-integration methods. For instance, reprogramming could be achieved using viral vectors including retroviruses,
lentiviruses and more recently Sendai non-integrating virus. Alternatively, non-viral methods include mRNA or protein delivery or transient expression achieved with
episomal plasmids. Pluripotent stem cells are defined by the presence of specific markers including cell surface proteoglycans (TRA-1-60 and TRA-1-81) and
glycosphingolipids (SSEA-3 and SSEA-4) and the expression of transcription factors OCT4 and SOX2 (Thomson et al., 1998; Tonge et al., 2011). The resulting
pluripotent cells, have the same embryonic plasticity for differentiating into almost any tissue type of the three germ layers (endoderm, mesoderm and ectoderm)
when stimulated by the appropriate signalling molecules and growth factors (Itskovitz-Eldor et al., 2000; Okita et al., 2013). Examples of cells derived from the germ
layers include nervous and epidermal tissue from the ectoderm, haematopoietic and muscle cells from the mesoderm, and pancreatic cells from the endoderm.
Copyright permission was obtained for the reproduction of images taken from Pacitti and Bax (2018).
Subsequent studies improved methodologies to differentiate
ESCs to neural precursors in the complete absence of serum
or growth factors (Ying et al., 2003). The combination of
the embryoid body-derived rosette and the serum free media
provided the foundation for the serum-free embryoid bodies
culture, which in the presence of inductive signals, including Wnt
and Nodal antagonists (Dkk1 and LeftyA, respectively) and Sonic
hedgehog could generate forebrain (telencephalic) precursors on
poly-D-lysine/laminin/fibronectin coated dishes (Watanabe et al.,
2005) and could be further differentiated into cortical neurons
(Gaspard et al., 2008).
However, because ESCs are of embryonic origin, they are
subjected to considerable ethical and practical issues. The
development of iPSCs has since introduced an advantageous
tool for the study of neurodevelopment and neuropathology;
the possibility of generating ESC-like cells from adult somatic
cells, not only circumvents issues related to ethics and sample
acquisition, but also provides the advantage of developing
pluripotent lines directly from diseased patients, and hence the
study of neurobiology and neurological disorders accounting
for genetic variations within a more heterogeneous cohort of
relevant genotypes/phenotypes (Avior et al., 2016). In fact, the
same differentiation protocols can be applied to the generation of
iPSCs for the provision of neural progenitors and specific neural
lineages (Mariani et al., 2012).
Several different PSC differentiation methods were developed,
although these are highly variable and unpredictable due to
undefined factors such as the use of neural inducing stromal
feeder cells, the heterogeneous nature of embryoid bodies and
inefficient methods for the selective survival of neural cells
(Schwartz et al., 2008; Denham and Dottori, 2011).
The development of neuralization protocols for PSCs has
been one of the main areas of investigation in neuroscience
and it is being achieved by the improved understanding of
the underlying signalling pathways involved, leading to the
development of more efficient methodologies such as dual SMAD
inhibition (Chambers et al., 2009). The dual SMAD inhibition
was accomplished by using Noggin and the small molecule
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SB431542 to inhibit the NODAL/Activin, TGF-β and bone
morphogenic protein (BMP) signalling, thereby inhibiting the
differentiation into cells with a non-neural fate (Chambers et al.,
2009; Pauklin and Vallier, 2015). The dual SMAD inhibition
method obviated the need for stromal cells and embryoid
body based techniques and permitted the efficient generation
of a broad repertoire of PSC-derived neural progenitors within
shorter differentiation times in adherent monolayer cultures
(Chambers et al., 2009). The dual SMAD inhibition method
was further improved by the addition of a glycogen synthase
kinase 3 (GSK3) inhibitor to induce Wnt signalling activation,
yielding progenitors which matched the gene expression profiles
of developing foetal brains, and with a broad range of regional
differentiation phenotypes, from rostro-caudal to midbrain and
dorso-ventral patterning of neural progenitors (Kirkeby et al.,
2012). In another experiment, dual SMAD inhibition was
combined with retinoid signalling to enhance differentiation of
PSCs to cortical neurons (Shi et al., 2012b).
Lineage priming of PSCs to the neural lineage has also been
achieved by the forced expression of the single transcription
factor Neurogenin-2 (or NeuroD1) which yielded the generation
of mature neurons expressing glutamatergic receptors and
forming spontaneous synaptic networks within 2 weeks from
transfection (Zhang et al., 2013). Another study demonstrated
that the forced synergistic expression of the transcription factors
ASCL1 and DLX2 induced the differentiation of PSC to near pure
GABAergic neurons (Yang et al., 2017).
Another common differentiation protocol uses retinoic acid
treatment on embryoid bodies for promoting commitment to
the neural lineage (Schuldiner et al., 2001). In participation with
FGF and Wnt, retinoic acid is a potent caudalizing factor of
the neuroectoderm and is a differentiation-inducing molecule
essential for the development of the neural crest and the
generation of cortical neurons (Villanueva et al., 2002; Diez
del Corral and Storey, 2004; Siegenthaler et al., 2009). Retinoic
acid has been demonstrated to inhibit neural proliferation and
promote neurogenesis by inhibiting the expression of genes that
negatively regulate neuronal differentiation (such as Notch and
Geminin), while promoting the expression of proneural and
neurogenic genes (Janesick et al., 2015). However, it is important
to note that although retinoids play a fundamental regulatory
role during neural tube formation, their function in neural
development and axial patterning are strictly context, time and
dose-dependent, and therefore it is crucial to include retinoids at
an appropriate differentiation stage in cultures (Maden, 2002).
MONOLAYER CULTURES
TO ORGANOIDS
With the improvement of differentiation methods, culturing
techniques have also been refined to introduce structural
complexities that better recapitulate the in vivo development
and cytoarchitecture. Availability of this technology has led to
a tremendous interest from researchers worldwide, particularly
from the prospective of generating more representative models
of the human phenotype, and as a means to “replace, reduce
and refine” the use of animal models (Sneddon et al., 2017).
The culture substrate is as essential to neural cell culture as
the use of appropriate inducing factors. In the CNS, extra
cellular matrixes (ECMs) are crucial for cell migration and
differentiation, therefore in vitro substrates are fundamental
for the preferred differentiation of NSCs and support of
differentiated cells (Franco and Müller, 2011).
The best-described substrates used for the in vitro culture
of neural cells (whether NSC or PSC-derived) are poly-L-
ornithine, poly-L-lysine, fibronectin, collagen and laminin (Ge
et al., 2015). All these substrates have been found to support
neural differentiation to differing degrees (Ma et al., 2008).
One study reports that poly-L-ornithine induces preferred
differentiation of NSCs into neurons and oligodendrocytes,
compared to poly-L-lysine and fibronectin (Ge et al., 2015).
However, other studies suggested that laminin or laminin-rich
substrates enhance differentiation of NSC to neurons (Hall et al.,
2008; Ma et al., 2008).
Nevertheless, the ECM is a complex mixture of molecules
(laminins, proteoglycans, collagens) and therefore specific
combinations of substrates may be necessary to better reproduce
the in vivo scenario (Ma et al., 2008; Franco and Müller, 2011).
Hydrogel scaffolds such as Matrigel, which consist of a mixture
of extracellular molecules including laminin, collagen IV, heparan
sulphate proteoglycans and entactin (Kleinman and Martin,
2005) are often successfully employed for the culture and long-
term support of neural cells (Ma et al., 2008; Lee et al., 2015).
Matrigel is not only advantageous as a substrate for monolayer
cultures, but due to its polymerizing nature, it can be utilised
as a semi-solid scaffold matrix for 3-D cultures (Tibbitt and
Anseth, 2009). However, even Matrigel is not immune from
major limitations, being an animal-derived matrix characterised
by batch variation and with an undefined composition that
may produce a source of variability in experimental conditions
(Hughes et al., 2010).
Traditional 2-dimensional (2-D) culturing has contributed
immensely to the understanding of neuroscience but is
substantially limited for recapitulating the in vivo complexities
of the CNS. Advancement in cell culturing techniques for
the generation of neural cell lines has greatly improved
with the directed differentiation of iPSCs into monolayers
of specific neural cell types (Pasca et al., 2014; Barral and
Kurian, 2016; McKinney, 2017). A summary of various CNS
neural tissues derived from the differentiation of iPSC is
presented in Table 1.
However, these 2-D cultures are unlikely to recapitulate the
intricate cytoarchitecture, the elaborate network of diverse neural
cell types and the functional complexity of the in vivo CNS
(Pas¸ca, 2018). Cell differentiation and maturation is critically
dependent on both intrinsic and extrinsic cues originating from
the interactions with various neural cells and ECM molecules,
and the cross-talk and dynamic interaction of neural cells is
crucial for the recapitulation of a physiologically relevant system
(Gomes et al., 2001; Rowitch and Kriegstein, 2010; Jiang and
Nardelli, 2016).
Nevertheless, 2-D cultures have the advantage of a greater
scalability, with less complex directed differentiation approaches
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TABLE 1 | Summary of different CNS neural cells differentiated from iPSC.
Disease group Disease modelled Genetic/
chromosomal
abnormality
iPSC-derived cells Reprogramming method Reference
Lysosomal storage
disorders
Jansky–Bielschowsky
disease
CLN5 CLN5 neurons Sendai-virus transduction Uusi-Rauva et al., 2017
Batten disease CLN3, TPP1 CLN3 neurons Retrovirus transduction Lojewski et al., 2014
Pompe disease GAA Pompe neurons Retrovirus transduction Higuchi et al., 2014
Niemann-Pick type C1 NPC1 NPC1 neurons, astrocytes Retrovirus transduction,
lentivirus transduction
Trilck et al., 2013
Efthymiou et al., 2015
Metabolic disorders Lesch–Nyhan syndrome HPRT Neurons Retrovirus transduction Mastrangelo et al., 2012
Gaucher’s disease GBA1 Dopaminergic neurons,
neurons
Lentivirus transduction Panicker et al., 2012
Tiscornia et al., 2013
Awad et al., 2015
Sun et al., 2015
Metachromatic
leukodystrophy
ARSA Neural stem cells, astroglial
progenitor cells
Retrovirus transduction Doerr et al., 2015
X-linked
Adrenoleukodystrophy
ABCD1 Neurons, astrocytes,
oligodendrocytes
Retrovirus transduction,
lentivirus transduction
Jang et al., 2011
Baarine et al., 2015
Neurodegenerative
disorders
Parkinson’s disease (PD),
idiopathic PD
LRRK2,
?
Midbrain dopaminergic
neurons
Cre-recombinase excisable
viruses, retrovirus
transduction
Soldner et al., 2009
Nguyen et al., 2011
Sanchez-Danes et al., 2012
Fernandez-Santiago et al.,
2015
Amyotrophic lateral
sclerosis (ALS)
TDP-43,
SOD1
Spinal motor neurons,
astrocytes
Retrovirus transduction,
TALEN transfection,
sendai-virus transduction,
episomal transfection
Bilican et al., 2012
Egawa et al., 2012
Serio et al., 2013
Yang et al., 2013
Bhinge et al., 2017
Neurodevelopmental
disorders
Rett syndrome TRPC6,
MECP2
Neural progenitor cells,
glutamatergic neurons,
astrocytes
Retrovirus transduction Muotri et al., 2010
Marchetto et al., 2010
Ananiev et al., 2011
Kim et al., 2011
Williams et al., 2014
Djuric et al., 2015
Griesi-Oliveira et al., 2015
Tang et al., 2016
Atypical Rett syndrome CDKL5 Glutamatergic neurons,
GABAergic neurons
Lentivirus transduction,
retrovirus transduction
Amenduni et al., 2011
Ricciardi et al., 2012
Timothy syndrome CACNA1C Neural progenitor cells,
cortical glutamatergic
neurons
Retrovirus transduction Pasca et al., 2011
Tian et al., 2014
Down Syndrome Trisomy 21 Cortical glutamatergic
neurons
Lentivirus transduction Shi et al., 2012a
Familial dysautonomia IKBKAP Neural crest precursors Lentivirus transduction Lee et al., 2009, 2012
Fragile X Syndrome FMR1 Neural progenitor cells,
forebrain neurons, glial cells
Retrovirus transduction,
episomal transfection
Urbach et al., 2010
Doers et al., 2014
Park et al., 2015
Halevy et al., 2015
Cockayne syndrome ERCC6 Neural progenitor cells Sendai-virus transduction Vessoni et al., 2016
Angelman/Prader-Willi
syndromes
UBE3A Neurons, astrocytes Retrovirus transduction Chamberlain et al., 2010
Phelan-McDermid
syndrome
22q13 deletion Forebrain neurons Retrovirus transduction Shcheglovitov et al., 2013
Neuropsychiatric
diseases
Frontotemporal dementia
(FTD)
CHMP2B,
C9ORF72
Forebrain cortical neurons Retrovirus transduction,
episomal transfection
Almeida et al., 2013
Zhang et al., 2017
Epilepsy Dravet syndrome SCN1A Dopaminergic, GABAergic,
glutamatergic neurons,
forebrain interneurons, glial
cells
Retrovirus transduction Higurashi et al., 2013
Jiao et al., 2013
Liu et al., 2013, 2016
(Continued)
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TABLE 1 | Continued
Disease group Disease modelled Genetic/
chromosomal
abnormality
iPSC-derived cells Reprogramming method Reference
Early infantile epileptic
encephalopathy
STXBP1 GABAergic, glutamatergic
neurons
Episomal transfection Yamashita et al., 2016
Neuromuscular
disorders
Spinal muscular atrophy
(SMA)
SMN1 Forebrain, sensory, motor
neurons, astrocytes
Lentivirus transduction,
retrovirus transduction,
episomal transfection
Ebert et al., 2009
Chang et al., 2011
Sareen et al., 2012
Corti et al., 2012
McGivern et al., 2013
Schwab and Ebert, 2014
Yoshida et al., 2015
Boza-Moran et al., 2015
Ng et al., 2015
Nizzardo et al., 2015
Liu et al., 2015
Fuller et al., 2015
Xu et al., 2016
Patitucci and Ebert, 2016
Movement disorders Huntington’s disease HTT Medium spiny neurons Lentivirus transduction The Hd iPsc Consortium, 2012
Hereditary spastic
paraplegia
SPG3A, SPG4,
SPG11, ATL1,
SPAST
Cortical neural progenitor
cells, forebrain,
glutamatergic neurons
Lentivirus transduction,
episomal transfection,
retrovirus transduction
Denton et al., 2014
Havlicek et al., 2014
Zhu et al., 2014
Mishra et al., 2016
Ataxia telangiectasia ATM Neural progenitor cells,
GABAergic neurons
Lentivirus transduction Nayler et al., 2012
Carlessi et al., 2014
Friedrich’s ataxia FXN Neural progenitor cells,
neural crest cells, peripheral
sensory neurons, glial cells
Retrovirus transduction,
lentivirus transduction,
transposon transfection
Liu et al., 2011
Eigentler et al., 2013
Hick et al., 2013
Bird et al., 2014
Neural cells characteristic of the CNS have been generated by directed differentiation of pluripotent stem cell derived lines, to recapitulate specific cell types or
disease condition.
and facilitated imaging. However, 2-D cells also favour stronger
interactions with the surfaces of the culturing vessel rather than
cell–cell interactions or between cells and the ECM, altering their
proliferation and differentiation capabilities (Pas¸ca, 2018). Three
dimensional models can overcome 2-D culturing limitations,
allowing the dynamic interactions between cells and ECMs and
the recreation of signalling, metabolites and oxygen gradients
across the culture (Ko and Frampton, 2016).
A variety of 3-D culture methods have been developed, with
one example in the form of tissue explant cultures, such as whole
brain sections grown in culture dishes or microfluidic devices
(Ullrich et al., 2011; Huang et al., 2012).
For instance, recently, an organotypic human Alzheimer
disease model consisting of a 3-D triculture system of
neurons, astrocytes and microglia co-cultured in a microfluidic
system was engineered. Authors developed this 3-D culture
system to model the neuroinflammation and neurodegeneration
aspects of the disease, employing human iPSC-derived NSCs
overexpressing mutant APP and PSEN1 genes associated with
familial Alzheimer’s. This system successfully recapitulated the
tauopathy, β-amyloid accumulation and microglia mediated
neuroinflammation more efficiently than the 2-D models
(Park et al., 2018).
However, these cultures are often problematic to maintain
in the long-term and are generally derived from animal
sources, and hence not representative of human development
(Ko and Frampton, 2016). Self-organised aggregate cultures are
an alternative 3-D in vitro culture approach, encompassing neural
spheroids (Dingle et al., 2015). Further sophistication of culture
methods has led to the modification of self-aggregating cultures
for the generation of organ-like structures, termed organoids
(Kelava and Lancaster, 2016b).
Central nervous system organoids can be divided in two
categories based on their patterning approach, either being self-
patterned or extrinsically patterned. Self-patterned organoids
are organoids that are cultured without the addition of
exogenous morphogens that favour specific brain regions,
whereas extrinsically patterned organoids refer to the generation
of brain specific regional identities via the addition of
morphogens and neurotrophic factors such as FGF, Sonic
Hedgehog, Nodal, Wnt and BMP (Clevers, 2016; Brawner et al.,
2017). Figure 4 illustrates the different brain regionals identities
recapitulated in CNS organoids.
To illustrate this, the seminal study of Eiraku et al. (2008)
demonstrated that serum-free embryoid bodies with quick
reaggregation are capable of self-organising into stratified cortical
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tissues in cultures, thus showing that ESCs spontaneously
differentiate toward a neural state by default. This notion
provided the fundaments to generate the first self-patterned CNS
organoid, employing serum-free embryoid bodies to generate
neuroepithelial cysts, which further self-organised into optic
cup organoids, to present regions with retinal identities upon
treatment with Nodal protein and culture on Matrigel basement
membrane (Eiraku et al., 2011).
Extrinsic-patterning organoids can be exemplified by
the generation of the first dorsal telencephalon organoid
recapitulating a human cerebral cortex at 8–10-week gestation
by Mariani et al. (2012), where serum-free embryoid bodies
were treated with Wnt and TGF-β inhibitors and cultured on
poly-L-ornithine, laminin and fibronectin for up to 70 days.
Similarly, other adaptations of the method developed by
Eiraku and colleagues led to the generation of neocortical
forebrain organoids maintained on Matrigel for over 3 months
(Kadoshima et al., 2013). Further modifications of protocols
for the generation of organoids patterned with other brain
specific regions and sub-regions have been developed to model
the adenohypophysis (using hedgehog agonists) (Suga et al.,
2011), hypothalamus (by Nodal/Activin/TGF-β, and BMP
mediated inhibition) (Wataya et al., 2008), cerebellum (using
the Nodal/Activin/TGF-β inhibition and the addition of FGF2
and FGF19) (Muguruma et al., 2015), midbrain (by using the
dual SMAD inhibition and Wnt activation) (Jo et al., 2016)
and hippocampal-choroid plexus (by treatment with BMP and
Wnt) (Sakaguchi et al., 2015). Combining the strong neuralizing
dual SMAD inhibition with the serum-free embryoid body
approach also enabled the generation of cortical spheroids,
which represented 3-D tissues containing neurons and astrocytes
and mimicked cortical development stages up to the mid-foetal
period (Pasca et al., 2015).
Lancaster and Knoblich (2014) introduced, for the first time,
the concept of whole-brain organoid or cerebral organoids
(Figure 5), representing different brain regions within the same
3-D platform. Cerebral organoids, are generated from PSC-
derived serum-free embryoid bodies obtained by culturing in low
concentrations of bFGF-2 and with ROCK inhibitors to promote
cell survival (Lancaster and Knoblich, 2014). The serum-free
embryoid bodies are subsequently induced to differentiate to the
neuroectoderm within suspension cultures, establishing a radially
organised neuroepithelium around the spheroid (Lancaster and
Knoblich, 2014; Sutcliffe and Lancaster, 2017).
The resulting neurospheres are embedded into Matrigel
hydrogel droplets, allowing the growth of continuous and
orientated neuroepithelial buds and, the apicobasal expansion
of the layer of neuroepithelial cells throughout the ECM
basement scaffold. After the embedding, budding neuroepithelia
generate fluid filled cavities reminiscent of ventricles. The
neuroepithelium begins to migrate outwardly to generate
the cortical layers consisting of Cajal-Retzius cells, deep
and superficial cortical progenitors. On exposure to retinoic
acid, cerebral organoids self-organise through self-patterning
mechanisms to display sparse populations of neural progenitors
including radial glia, which begin to expand forming cerebral
structures (Lancaster and Knoblich, 2014). Retinoic acid is
only added for terminal differentiation, as being a potent
caudalizing factor it inhibits neurogenesis in the early stages of
neuroepithelium formation (Petros et al., 2011).
The region in which radial glia originate, recapitulates
the in vivo ventricular zone (VZ) and SVZ (Kelava
and Lancaster, 2016a). Therefore, similar to in vivo
neurogenesis, neural progenitors migrate to form the
cortical plate, spontaneously giving rise to distinct brain
regions reminiscent of the dorsal cortex, ventral forebrain,
hindbrain, midbrain, retina, hippocampus and choroid plexus
(Lancaster and Knoblich, 2014).
As cerebral organoids expand in culture, the neuronal
population increases in number, resulting in the enlargement
of tissues, reaching sizes of up to 4 mm in diameter (Sutcliffe
and Lancaster, 2017). The whole development process requires
7–10 days for the generation of neurospheres, and more
than 20 days before the appearance of the first mature
neural population (Lancaster and Knoblich, 2014; Sutcliffe
and Lancaster, 2017). After 1 month in culture the cerebral
tissue begins to thicken, showing tissues of different regional
identities, as evidenced by the expression of FOXG1 (forebrain),
TTR (choroid plexus), FZD9 (hippocampus) and SOX2 (VZ
radial glia) (Lancaster and Knoblich, 2014). Later studies have
confirmed that cerebral organoids display with high fidelity
the gene expression signatures of a foetal developing neocortex
(Camp et al., 2015).
The increase in size introduces problems with regard to
nutrient and oxygen diffusion through the central regions
of tissue, causing necrosis (Lancaster and Knoblich, 2014).
Therefore, the organoids are grown in spinning bioreactors to
provide agitation and maximise oxygen and nutrient exchange
(Kelava and Lancaster, 2016b). Within bioreactors, cerebral
organoids are capable of displaying a longevity of up to 1 year,
although it has been reported that growth becomes stationary
after 5 months, with organoids shrinking in size in subsequent
months due to neuronal loss and disappearance of progenitors
(Lancaster and Knoblich, 2014).
MODELLING NEUROLOGICAL
DISORDERS WITH CNS ORGANOIDS
Since the generation of the first brain organoids, unsurprisingly,
there has been an exponential surge in publications employing
this technology (Figure 6), due to their amenability for the
study of neurodevelopment and neurological diseases, but
also as a potential platform for the development of novel
neurotherapeutics. When searching Pubmed using the terms
“Cerebral organoid,” “Brain organoid,” “CNS organoid,” and
“Cortical organoid” the number of publications for the year
2013 were 4, compared to 52 and 77 for the years 2017
and 2018, respectively. Due to the significant expansion and
importance of this technology, this section of the review will
primarily focus on the applications and advancements in this
field. Cerebral organoids are indeed a relatively new platform
but are finding wider application as in vitro disease modelling
tools, not only for many developmental disorders, but also for
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FIGURE 4 | Different brain regional identities recapitulated by CNS organoids. The diagram summarises the various patterning methods developed to generate
region specific CNS organoids. Copyright permission was obtained for the reproduction of images taken from Lancaster et al. (2013); Muguruma et al. (2015), Pasca
et al. (2015); Sakaguchi et al. (2015), Jo et al. (2016); Qian et al. (2016).
FIGURE 5 | Cerebral organoid formation. Cerebral organoids originate from pluripotent stem cell derived embryoid bodies cultured in low concentrations of bFGF-2
and with ROCK inhibitors to prevent anoikis. The embryoid bodies are differentiated toward neuroectoderm, resulting in the formation of neurospheres, which are
embedded into Matrigel hydrogel droplets. After the embedding, budding neuroepithelia generate fluid filled cavities reminiscent of ventricles. The neuroepithelium
begins to migrate outwardly to generate the cortical layers consisting of Cajal-Retzius cells, deep and superficial cortical progenitors. On exposure to retinoic acid,
cerebral organoids self-organise through self-patterning mechanisms to display diverse populations of neural progenitors including radial glia, which expand forming
cerebral structures (Lancaster and Knoblich, 2014). The region in which radial glia originate, recapitulates the in vivo VZ and SVZ (Kelava and Lancaster, 2016a).
Prior to neurogenesis, radial glia are formed from the neuroepithelial cells and facilitate the migration of the neural and glial progenitors (Howard et al., 2008; Johns,
2014); these cells are characterised by the asymmetric self-renewal division leading to the generation of one neuron and one radial glia (Gotz and Huttner, 2005;
Lancaster and Knoblich, 2012). Radial glia migrate, establishing the SVZ, where cells divide symmetrically forming intermediate progenitors (Haubensak et al., 2004;
Miyata et al., 2004). Radial glia produce outer radial glia in the SVZ, which are self-renewing (Fietz et al., 2010; Hansen et al., 2010). Radial glia residing in the VZ
divide at the apical surface adjacent to the ventricle. Intermediate progenitors and basal radial glia migrate basally to the SVZ. Neurons formed from radial glia,
migrate radially from the ventricular and SVZ toward the basal region to establish the cortical plate (Johns, 2014; Kelava and Lancaster, 2016a). The neuronal
migration depends on a layer of Cajal-Retzius cells and the outward migration is regulated by the protein reelin secreted by the latter cells (Frotscher, 1998). Within
the intermediate zone of the cerebral hemispheres, neurons undergo apoptosis, and the region becomes the subcortical white matter (Johns, 2014).
psychiatric diseases and neurodegenerative conditions (Lancaster
et al., 2013; Mariani et al., 2015; Garcez et al., 2016; Jo
et al., 2016; Kelava and Lancaster, 2016a; Raja et al., 2016;
Bershteyn et al., 2017; Birey et al., 2017; Iefremova et al., 2017).
The advent of genome editing techniques such as CRISPR/Cas9
has changed the scene for tackling genetic disorders and opened
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a new chapter for potential stem cell applications in the clinic
(Waddington et al., 2016). In particular, organoids’ versatility
and adaptability to genome editing techniques or gene therapy
approaches make them valuable candidates for the identification
and testing of novel therapeutic approaches (Yin et al., 2016;
Gonzalez-Cordero et al., 2018).
Microcephaly
Lancaster and colleagues generated organoids from a patient
harbouring a CDK5RAP2 mutation, and demonstrated that the
organoids from the patient with microcephaly were smaller
compared to a healthy control. This was explained by fewer
proliferating progenitors and a premature differentiation in the
disease tissues. The group also demonstrated that the phenotype
could be rescued by inducing the expression of the wild-type gene
(Lancaster et al., 2013).
Furthermore, cerebral organoids have aided the
understanding of microcephaly associated with neuroinfection
with the Zika virus. In the study of Garcez et al. (2016) human
cortical organoids infected with Zika virus exhibited a 40%
decrease in size compared to non-infected controls. An elegant
study by Qian et al. (2016) introduced an innovation in culturing
cerebral organoids through the use of miniaturised spinning
bioreactors (the Spin), and the authors determined that
infection of organoids with Zika virus resulted in an increase
in apoptosis with consequent reduction in cell proliferation
and a marked thinning of the ventricular zone. Another study
found that human iPSC-derived cerebral organoids infected with
Zika virus had a decrease in PAX6 expressing progenitors in the
proliferative zones and consequently a decrease in differentiated
neurons leading to a disruption in the cortical plate formation
(Cugola et al., 2016). Dang et al. (2016) found that Zika virus
infection in organoids induced a significant upregulation of
Toll-like receptor 3 gene, leading to apoptosis and dysregulation
of neurogenesis.
Macrocephaly
Li et al. (2017) demonstrated the recapitulation of macrocephaly
in cerebral organoids, by the genetic ablation of PTEN using
CRISPR/Cas9. Edited organoids exhibited an activation in AKT
signalling in neural progenitors regulating cortical maturation,
resulting in a delay in neuronal differentiation, an increase in
cellular proliferation or radial glia progenitors, and a significant
increment in organoid sizes (Li et al., 2017).
Autistic Spectrum Disorder
Mariani and colleagues employed iPSCs derived from patients
with idiopathic autism spectrum disorder to generate cerebral
organoids; the patient tissues exhibited an overgrowth of neurites
and synapses, in a similar fashion to that observed in post mortem
brain investigations of individuals with autism. The same study
observed an increased production of GABA-ergic inhibitory
interneurons in patient organoids, while also identifying an
upregulation of FOXG1, thus indicating a correlation between
the two observations (Mariani et al., 2015). Using cerebral
organoids combined with monolayer cultures, Mellios et al.
(2017) characterised defects in neurogenesis associated with
MeCP2 deficiency in Rett syndrome, which consisted primarily
in expanded ventricular zones with enhanced PAX6+ ventricle-
like structures. In this study, through the inhibition of miR-
199, affected signalling pathways (PKB/AKT and ERG/MAPK)
were rescued and the dysregulations in neural differentiation
ameliorated (Mellios et al., 2017).
Miller-Dieker Syndrome
Miller-Dieker syndrome, a form of lissencephaly, was modelled
using patient-derived iPSCs, enabling the identification of
a stalled mitosis of outer radial glia, thus suggesting that
dysfunctions in progenitor cell cycles could be a feature of cortical
malformations in the disease (Bershteyn et al., 2017). Another
study identified non-cell autonomous defects in Wnt signalling
associated with Miller-Diekers syndrome (Iefremova et al., 2017).
Sandhoff Disease
Allende et al. (2018) developed cerebral organoids from iPSCs
derived from an infant with Sandhoff disease and from isogenic
controls corrected for the HEXB mutation by gene editing. The
authors demonstrated that GM2 ganglioside only accumulated
in the disease organoids and affected organoids displayed an
increase in size and cellular proliferation compared to the
isogenic control counterpart (Allende et al., 2018).
Schizophrenia
In their study examining the association of DISC1 gene with
schizophrenia, Ye et al. (2017) used human cortical organoids
to demonstrate that DISC1/Ndel1 interactions regulate mitotic
events in NSCs and that a delay in mitosis was observed in
organoids derived from a patient with a DISC1 mutation.
Modelling Prenatal and Perinatal Drug
Exposure
Cerebral organoids have been used to investigate how the
prenatal exposure to substances of abuse including illegal drugs,
alcohol and tobacco affect neurogenesis. A study examining
the exposure of cocaine, demonstrated that cytochrome P450
CYP3A5-mediated oxidative metabolism was responsible for the
developmental abnormalities of the foetal neocortex, resulting
in the inhibition of neuroepithelial progenitor proliferation,
premature neuronal differentiation and a reduction in the
cortical plate formation (Lee et al., 2017). Zhu et al. (2017a)
investigated the effects of ethanol exposure in organoids to
better understand alcohol-induced defects in neurogenesis in
foetal alcohol syndrome, and where able to identify through
a transcriptome analysis, gene expression alterations in the
Hippo pathway and in other genes including GSX2 and
RSPO2. Another study using organoids-on-chip investigated
the effect of nicotine on neural development, demonstrating
a disruption in cortical development in exposed organoids
(Wang et al., 2018). The use of organoids for studies on
the effect of drug exposure on embryonic CNS development
would not be limited to substances of abuse, but could
also be used in the context of neurodevelopmental toxicity
whereby toxicological profiles of compounds on teratogenicity or
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FIGURE 6 | Frequency of publications reporting the use of CNS organoids by year. The chart illustrates a surge in publications involving the use of CNS organoids,
between 2014 and 2018.
neurotoxicity could also be assessed in the system, such as for
the evaluation of the neural teratogenic effect of valproic acid
or the effect of environmental chemicals (Schwartz et al., 2015;
Miranda et al., 2018b; Wood et al., 2018).
Alzheimer’s Disease
The limitations of cerebral organoids in recapitulating
only early neurogenesis, hinders their application for
studying late-onset neurodegenerative diseases such as
Alzheimer’s, Parkinson’s and Huntington’s (Kelava and
Lancaster, 2016a). Nevertheless, Raja et al. (2016) developed
cerebral organoids derived from patients with early onset
familial Alzheimer’s, and were able to recapitulate the
disease phenotype through the demonstration of β-amyloid
aggregation, hyperphosphorylated tau proteins and abnormal
endosomes. The authors further demonstrated that β-amyloid
and tau pathologies were significantly reduced when
treating patient organoids with β and γ secretase inhibitors
(Raja et al., 2016).
OTHER DEVELOPMENTS AND
APPLICATIONS
More recently, research groups have sought to optimise and
advance methods for the generation of more reproducible and
morphologically complex organoids. For instance, Basuodan
et al. (2018) have generated 3-D cultures with characteristics
similar to cerebral organoids by transplanting iPSC-derived
neurospheres embedded in ECM matrix, into brains of ischaemic
mice (Basuodan et al., 2018).
Organoids also provide a powerful tool for the study
of evolutionary developmental biology, and for comparing
neurogenesis between species in vitro (Giandomenico and
Lancaster, 2017). More recently, due to the advancement
in gene editing technologies, such as CRISPR/Cas9,
Neanderthal cerebral organoids were generated by
introducing the Neanderthal gene NOVA1 in human
iPSCs. This study demonstrated that Neanderthal brain
organoids resembled to a certain degree, organoids
generated from patients with autism, indicating that these
similarities may be linked to socialisation behaviours
(Cohen, 2018).
Moreover, organoids have been used to study cellular
migration, cross-talk and circuitry assembly by either generating
region-specific organoids and fusing them, or by co-culturing
cells from different lineages in a single organoid, and thus
generating structures referred to as assembloids (Birey et al., 2017;
Workman et al., 2017; Pham et al., 2018). By using this approach,
forebrain assembloids derived from patients with Timothy
syndrome, were shown to have defects in the migration of cortical
interneurons, and these could be restored pharmacologically
by modulating the mutated L-type calcium channel, thus
contributing significantly to the understanding of epilepsy and
autism associated with the syndrome (Birey et al., 2017).
The substantial versatility of organoid applications is
demonstrated in the interesting experiment conducted by
Mattei and colleagues, where cerebral organoids were employed
to investigate how neurogenesis and neural development
could be affected by microgravity. In projection of spaceflight
advancements, the authors cultured human organoids in rotary
cell culture system to demonstrate that microgravitational
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changes influenced the expression of rostral-caudal patterning
genes and cortical markers (Mattei et al., 2018).
Literature reports on the ability of organoids to recapitulate
the composition of an adult CNS were elusive in the initial phases.
Seminal studies on the comparison of cerebral organoids to foetal
brains, initially suggested that the development of fully matured
cerebral organoids could only parallel the early embryonic
cerebral development observed at 8–10 weeks gestation (Mariani
et al., 2012; Kelava and Lancaster, 2016a,b). However single cell
sequencing experiments have revealed that organoids are capable
of replicating late-mid foetal periods of a 19–24 weeks gestational
brain (Pasca et al., 2015).
Given the ability of organoids to recapitulate developmental
timing, much interest has also been directed at the types of
CNS neural cell populations which compose organoids and
their maturation stage, such as glial cells. A recent study
conducted by Monzel et al. (2017) reported the presence of
differentiated glial cells in midbrain organoids from as early
as day 27 of development, with myelinating oligodendrocytes
ensheathing neurites at day 61 (Monzel et al., 2017). Moreover,
the same study demonstrated that after 61 days, mature astrocytes
staining for S100β and AQP4 characterised mature midbrain
organoids (Monzel et al., 2017). Additional studies have further
demonstrated that cerebral organoids cultured for prolonged
periods, ranging from months up to 1.5 years, displayed the
presence of differentiated astrocytes and oligodendrocytes (Camp
et al., 2015; Renner et al., 2017; Matsui et al., 2018). Furthermore,
using culture times of over a year has been shown to yield
organoids exhibiting a large proportion of mature glial cells and
gene expression profiles comparable to those of post-natal brains
(Renner et al., 2017; Sloan et al., 2017).
Our group has used cerebral organoids to model
mitochondrial neurogastrointestinal encephalomyopathy
(MNGIE), a rare metabolic disorder which manifests with
leukoencephalopathy amongst other neurological and
gastrointestinal symptoms (Pacitti, 2018; Pacitti and Bax,
2018). The ability of organoids to produce differentiated
astrocytes and myelinating oligodendrocytes, and most
importantly the recreation of a physiologically relevant cross-
talk between cells has been a great asset for investigating the
leukodystrophic manifestations of the disease and shed light on
the poorly understood pathomolecular mechanisms of the CNS
involvement in MNGIE (Pacitti, 2018; Pacitti and Bax, 2018).
In comparison to 2-D cultures, brain organoids represent
a valuable tool for the study of glial cells as, for instance,
when dealing with astrocytes, traditional monolayer cultures
are inadequate since the morphological complexity and the
vast heterogeneity cannot be appropriately modelled (Imura
et al., 2006; Lange et al., 2012; Puschmann et al., 2013).
Also, astrocytes cultured in 2-D preferentially interact with
plastic surfaces rather than between cells and the ECM (Pas¸ca,
2018). Most importantly, astrocytes in 2-D cultures tend to
have an undesirably high baseline reactivity, possibly caused
by serum components, although this can be minimised by
using serum-free neurobasal formulations (Foo et al., 2011;
Pekny and Pekna, 2014; Pasca et al., 2015). However, iPSC-
derived astroglial cells in 2-D cultures require extensive timing
to allow for maturation, and thus practicalities inherent to long
term culturing of cell monolayers, for appropriate astrocyte
maturation, represent a major challenge (Dezonne et al., 2017;
Sloan et al., 2017). In addition to cell intrinsic properties,
astrocyte maturation may require interactions with other neural
cells types, which would not be represented in pure astrocyte
cultures differentiated by pluripotent cells, unless specifically
co-cultured after differentiation (Chandrasekaran et al., 2016).
Three dimensional cultures, like cerebral organoids, allow
the recreation of a more physiological spatial environment
that favours a representative organisation of astrocytes and
their interactions with other neural cells and ECM components
(Pasca et al., 2015; Liddelow and Barres, 2017). Compared to
2-D cultures, 3-D cultures have indeed demonstrated a better
capacity for recapitulating astrocyte heterogeneity (Puschmann
et al., 2013; Puschmann et al., 2014; Liddelow and Barres,
2017). Moreover, in 3-D cultures, basal reactivity of astrocytes
is negligible, rendering them the ideal platform for the study
of the heterogeneous spectrum of astrocyte subtypes and their
activation (Puschmann et al., 2013; Pasca et al., 2015; Liddelow
and Barres, 2017).
CURRENT CAVEATS AND
ADVANCEMENT IN THE ORGANOID
TECHNOLOGY
While cerebral organoids offer an advantageous culture system
with diversified neural cells for modelling as closely as
possible the intercellular interactions during organogenesis,
the technology also suffers from some limitations, which are
constantly being addressed with ongoing research efforts. One of
the greatest limitations of the 3-D platform is the confounding
batch variability (Di Lullo and Kriegstein, 2017; Pas¸ca, 2018). Cell
differentiation relies on spontaneous events that are characterised
by a high degree of stochasticity as they lack developmental axes
(Pas¸ca, 2018). This results in regional identities that could differ
in distribution, composition and densities between organoids,
generating concerns regarding reproducibility, accuracy and
scalability (Di Lullo and Kriegstein, 2017). The spontaneous
self-patterning mechanisms on which cerebral organoids rely,
results in the formation of several brain regional identities, when
compared to brain region-specific organoids. As such, cerebral
organoids are characterised by a great level of heterogeneity and
complexity, which result in morphological variabilities between
and within organoid batches, leading to inherent reproducibility
issues (Lancaster et al., 2013; Kelava and Lancaster, 2016a).
Referring to this elevated variability, Lancaster and colleagues
suggested that if using organoids to detect phenotypes in the
context of genetic disorders, defects must be robust enough
to be noticeable (Lancaster and Knoblich, 2014; Kelava and
Lancaster, 2016b; Giandomenico and Lancaster, 2017). In fact,
organoid variability could have severe implications with respect
to disease modelling, drug screening or neurodevelopmental
studies, as the heterogeneity could affect the consistency
of phenotypes exhibited, masking true differences between
diseased and healthy, or treated and non-treated tissues.
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Organoid variability would appear to be partly accountable to a
bioreactor-based effect, meaning that a more controlled growth
microenvironment would contribute to a better reproducibility
(Quadrato et al., 2017).
More recently, polymer microfilaments were implemented as
scaffolds to promote a more elongated generation of embryoid
bodies, which has been found to enhance neuroectoderm
formation and cortical development, and also reduce the issues of
reproducibility and variability observed in the regional identities
of filament scaffolded organoids (Lancaster et al., 2017).
Contrarily to the “intrinsic” self-patterning protocol,
patterning of organoids using inductive signals and optimised
bioreactors, as conducted by Qian et al. (2016), led to the
development of more consistent region specific organoids which
were less influenced by batch variability. Optimal patterning
and the relevant reproduction of proper developmental axes
requires a spatiotemporally defined gradients of morphogens,
which is challenging to achieve in culture; it has been suggested
that a way to circumvent this could be through the use of
slow-releasing microbeads to establish a morphogen gradient
(Lee et al., 2011; Sun et al., 2018). In contrast, a recent study
revealed that the removal of inductive factors such as those used
for the dual SMAD inhibition during the EB differentiation stage,
or refraining from using maturating growth factors in culture
medium during the organoid stage (such as BDNF, GDNF and
TGF-β), yields more optimal organoids with reduced inter and
intra batch variability in terms of reproducibility, size, growth
and neural cell composition and maturity (Yakoub and Sadek,
2018). Cerebral organoids generated through this optimised
protocol exhibited a robust neuronal zone and positive staining
for general neuronal and mature astrocytic markers, and were
characterised by a strong upregulation of neurotransmitter
receptor genes involved in synaptic functions including the
glutamate, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) receptor GluA1, and the N-methyl-D-aspartate
(NMDA) receptors GluN1, GluN2A and GluN2B, and the
γ-amino butyric acid (GABA) receptor GABA-B receptor 1
(Yakoub, 2019).
Potentially, the elevated variability observed in EB
preparations may contribute to the heterogeneity observed
between organoid preparations (Wilson et al., 2014). Therefore,
controlling this heterogeneity, deriving from the spatial
disorganisation and asynchronous differentiation of EB
aggregates, could further minimise reproducibility issues
observed during organoid development (Miranda et al.,
2015, 2018a). The use of centrifugal forced-aggregation and
silicon micro-textured surfaces improved symmetry, size and
synchronised differentiation in EB, increasing consistency
between preparations (Ungrin et al., 2008). Another example
of a possible bioengineering solution to control aggregate size
and size by cellular confinement, could be identified in the use
of microfabrication technologies where organoids cultured on
a micropillar array exhibited robust brain regionalization and
cortical organisation (Zhu et al., 2017b).
Organoids lack some cells of the CNS including endothelial
cells composing the cerebral vasculature, the blood–brain barrier
(BBB), and microglia, as these do not derive from ectodermal
tissues (Di Lullo and Kriegstein, 2017). These cells are found to
have a role in CNS development via extrinsic signals that induce
maturation and differentiation of neural cells including astrocyte
and cortical neurons (Stubbs et al., 2009; Cunningham et al.,
2013; Sloan et al., 2017).
The lack of vascularisation has been reported to prevent the
delivery of oxygen and small molecules deep inside the tissue,
often resulting in necrosis within the centre of the organoids.
Most importantly, the lack of vascularisation interferes with
certain patterning cues necessary for organoid development and
progenitor differentiation. Late developing brains are highly
dependent on vascularisation as niches of neural progenitors,
such as the SVZ, are generally found in proximity of vessels.
The solution to the limitations inherent to vascularisation and
stochastic patterning cues can only be sought by refinement of
the existing protocols, by either modifying culture conditions to
mimic the physiological environment as closely as possible or
through bio-engineering innovation to provide a flowing system
of nutrients to organoids to reproduce vascularisation (Kelava
and Lancaster, 2016a).
Recently, it has been suggested that combining organoid
culture with microfluidic technology may circumvent the
vascularisation issue, for example, by culturing endothelial cells
in microfluidic channels (Auger et al., 2013) to provide a flow
system of nutrients and trophic molecules, thus allowing the
in vitro modelling of organoid angiogenesis (Yin et al., 2016).
Having highlighted the lack of vascularisation and BBB as
major limitations of cerebral organoids, it has been envisaged
that the introduction of further structural complexities may
enhance the spectrum of applications of this platform (Kelava
and Lancaster, 2016a). Several groups have addressed the lack
of the BBB by generating vascularised organoids (Mansour
et al., 2018; Nzou et al., 2018; Pham et al., 2018). Pham
et al. (2018) generated vascularised cerebral organoids by re-
embedding organoids in Matrigel droplets, seeded with iPSC-
derived endothelial cells. Mansour et al. (2018), employed a
different approach and achieved the vascularisation of human
organoids, through engraftment in murine cortices in vivo.
This demonstrated the feasibility of integration with the host,
an improvement in viability and longevity of the tissue, a
synaptic connectivity of transplanted organoids and the host,
and ultimately, the formation of a microvascular network in the
grafted organoids (Mansour et al., 2018). Also, Nzou et al. (2018)
generated a six cell type cortical organoid consisting of astrocytes,
pericytes, oligodendrocytes, NSCs and vascular endothelial cells,
creating a functional BBB expressing tight and adherent junctions
to examine barrier permeability using neurotoxic compounds.
The structural complexity of cerebral organoids has its pros
and cons. Whereas the high degree of neural cell diversity and
complex cross-talks are an advantage, this may also represent
a disadvantage when trying to test hypotheses related to the
contribution of individual cell types to mechanistic processes.
The complementation of a 3-D model with a 2-D cell culture
system of purified cells of interest from the organoids would allow
the compartmentalisation and investigation of individual neural
cell types, enabling molecular mechanisms intrinsic to specific
cell types to be teased out.
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CONCLUDING REMARKS
Studies of neural development and neurodegenerative diseases
present many challenges due to the structural and functional
complexity of the CNS, together with the limited possibility
of in vivo experimental manipulation. Although animal
models have contributed to the current knowledge, there are
significant structural, cellular and molecular differences in the
CNS of animal and humans, making data extrapolation and
interpretation a formidable task. The past 100 years have seen
the evolution of a number of culture systems for modelling
the human CNS. Tissue explants and organotypic cultures
were replaced by 2-D cultures thereby permitting investigation
in more controlled systems. Issues of tissue availability were
addressed by the development of human neural cell lines
derived from tumours and more recently, the discovery of
NSCs has permitted the generation of neuronal and glial
cells in large quantities. Three-dimensional culture systems
(organoids) are the most recent technological development
in CNS modelling and bridge the gap between native tissue
and 2-D cell cultures. Many advancements have been made
in CNS organoid development, as evidenced by the ability of
culturing for prolonged times, the potential to recapitulate late
brain developmental milestones and in vivo transplantation.
However, ethical and epistemological issues have been raised
around organoids questioning their potential for developing
consciousness (Lavazza and Massimini, 2018; Shepherd, 2018).
At present, organoids can only recapitulate early stages of
development and can be used in a relatively narrow spectrum
of applications. However, their use is currently not free of
hindrances and thus continuous efforts must be made for
further improvement to overcome their limitations for a more
appropriate and reliable use. One of the major improvements
can be found in organoids-on-chip, which as opposed to
traditional organoids, are not self-assembled but are rather
constructed to produce a more reliable and consistent culture,
through the inclusion of engineered elements such as biosensors
and microfluidic channels (Tachibana, 2018). At present, the
excitement for this technology is driving elegant research
worldwide and it holds the potential for promising and
revolutionary applications.
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